News related to
Edge

HKUST Led Project Marks Hong Kong’s First Scientific Payload on the National Space Station

HONG KONG SAR – Media OutReach Newswire – 13 May 2026 – The world’s first lightweight, high‑resolution, high‑precision synergistic observatory for carbon dioxide (CO₂) and methane (CH₄) emission point sources – named “MUSICO”, Multi‑Spectral Imaging Carbon Observatory, led by The Hong Kong University of Science and Technology (HKUST) – was successfully launched aboard the Tianzhou‑10 cargo spacecraft on May 11 and has arrived at China’s Tiangong Space Station. This is not only Hong Kong’s first scientific payload deployed on the national space station, but also a historic breakthrough for the city in the development of high‑end aerospace instruments. The project fully demonstrates Hong Kong’s strong capability to build national‑level cutting-edge scientific payloads, to participate in long‑term space station missions, and to play a key role in addressing global climate change while serving the nation’s strategic “carbon peak and carbon neutrality” goals.

The project is led by an interdisciplinary research team from HKUST, comprising experts from the Department of Civil and Environmental Engineering, the Division of Emerging Interdisciplinary Areas, the Division of Environment and Sustainability, the Department of Computer Science and Engineering, and the Division of Public Policy. In late 2024, the project received formal approval from the Technology and Engineering Center for Space Utilization of the Chinese Academy of Sciences (CSU.CAS), the general research center for the Space Utilization System. It is jointly developed with the CAS Changchun Institute of Optics, Fine Mechanics and Physics, and funded by the Special Call (Aerospace Technology) of the Innovation and Technology Support Program under the Innovation and Technology Commission of the HKSAR Government.

MUSICO is a lightweight, high‑resolution, high‑precision greenhouse gas point‑source detection payload capable of accurately measuring CO₂ and CH₄ — two major greenhouse gases — from space. Smaller than a domestic washing machine, the instrument maintains extra-high spectral resolution and one hundred‑meter spatial resolution. By analyzing intensity changes of sunlight over specific spectral bands as it passes through the atmosphere and reflects off the Earth’s surface, MUSICO identifies gas‑specific absorption features to determine gas concentrations and pinpoint individual emission sources, enabling effective monitoring of key facilities such as power plants and landfills.

Prof. SUN Dong, Secretary for Innovation, Technology and Industry of the HKSAR Government, remarked, “This HKUST led project represents Hong Kong’s first scientific payload aboard the Tiangong Space Station, a major milestone for Hong Kong in the nation’s space missions. The national 15th Five Year Plan identifies accelerating green and low carbon transition, building a space powerhouse, and achieving carbon peak as key priorities. The successful deployment of a payload autonomously developed by a Hong Kong research team on Tiangong powerfully demonstrates that Hong Kong scientists possess top tier research and technology translation capabilities in frontier fields such as aerospace technology and green low carbon science, providing the nation with high quality, verifiable scientific data to accelerate the realization of the dual carbon goals.”

Prof. Nancy IP, President of HKUST, said, “We are deeply honored that our HKUST research team can participate in scientific missions on the national space station, and we sincerely thank the nation and the HKSAR Government for their long‑standing trust and support. This project not only highlights HKUST’s accumulated strengths in aerospace engineering, satellite remote sensing, and environmental engineering, but also proves that Hong Kong’s research capabilities can make substantial contributions on the nation’s highest‑level aerospace platforms. As the world’s first lightweight high‑precision greenhouse gas point‑source detection payload, MUSICO will continue to operate on the national space station, providing autonomous, controllable, high‑reliability CO₂ and CH₄ emission monitoring data that directly support the nation’s dual‑carbon goals and provide scientific backing for the ‘Beautiful China’ initiative and global climate governance.”

President Ip added, “In recent years, HKUST has been deepening its efforts in deep‑space exploration and low‑orbit satellite technology — following the successful launch of Hong Kong’s first higher‑education satellite in 2023, we are now actively participating in the nation’s Chang’e‑8 lunar exploration mission. Looking ahead, HKUST will continue to leverage its strengths in artificial intelligence, robotics, and materials science to accelerate the translation of space‑related technologies and nurture high‑end talent, contributing to the nation’s accelerated drive to build a space powerhouse and achieve green, low‑carbon, high‑quality development.”

Prof. SU Hui, Project Lead, Chair Professor of the Department of Civil and Environmental Engineering and Global STEM Professor at HKUST, said, “The development of MUSICO involved overcoming multiple critical technical challenges — namely, how to achieve high spectral resolution, fine spatial resolution, and synergistic multi‑gas observation under strict size and weight constraints. The team conducted extensive testing and optimization in optical design, precision manufacturing, and system integration to ensure the instrument can deliver reliable, accurate greenhouse gas data over long periods under high‑speed operation and extreme space environments. Successfully integrating these key technologies into a lightweight payload represents a landmark engineering and scientific achievement, demonstrating that the technology has reached internationally advanced standards.”

Prof. ZHANG Limin, Co‑Project Lead, National Engineer Awardee and Head of the Department of Civil and Environmental Engineering at HKUST, emphasized, “MUSICO’s observational coverage spans most land and ocean areas across low‑to‑mid‑latitude regions, providing consistent and comparable greenhouse gas monitoring data for different regions. The project’s results will be shared with government agencies and research institutions, supporting scientific research and practical applications in the Guangdong‑Hong Kong‑Macao Greater Bay Area and in other parts of China. They will also provide a scientific basis for cross‑regional climate research and emission reduction efforts along the Belt and Road, contributing to the global response to climate change. This is both a vivid example of HKUST’s research strength serving national strategy and a concrete practice of Hong Kong’s research capabilities contributing to global climate governance.”

The research project is co‑led by Prof. SU Hui, Chair Professor of the Department of Civil and Environmental Engineering and Global STEM Professor at HKUST, and Prof. ZHANG Limin, Chair Professor and Head of the same department. Prof. ZHAI Chengxing, Associate Professor of the Division of Emerging Interdisciplinary Areas serves as the mission system engineer. Other team members include: Senior Scientific Officer Dr. RONG Pingping, Prof. ZHANG Jize, and Prof. WANG Zhe from HKUST’s Department of Civil and Environmental Engineering; Prof. NING Zhi, Prof. SHI Xiaoming, and Prof. GU Dasa from the Division of Environment and Sustainability; Prof. MA Xiaojuan from the Department of Computer Science and Engineering; Prof. ZHU Pengyu from the Division of Public Policy; Prof. GAO Meng from Hong Kong Baptist University; and Prof. LI Jia from Lingnan University.

The project has also garnered strong industry support, including funding from HKUST-incubated startup Stellerus Technology Limited. Meanwhile, CLP Power Hong Kong Limited will collaborate with the project team to explore leveraging the data collected by MUSICO to complement its relevant assessments.

Hashtag: #HKUST

The issuer is solely responsible for the content of this announcement.

Taking place from May 12-14, 2026, the co-located events are expected to welcome 8,000 industry professionals from over 90 countries and regions. Spanning more than 30,000 sqm, the exhibition features over 150 brands showcasing next-generation technologies, immersive solutions, and digital infrastructure across the sector.

Against the backdrop of an estimated ~8% annual growth trajectory in Asia’s integrated resorts sector, according to a 2025 report by Research and Markets, the event underscores the region’s accelerating role as a global growth engine, where technology innovation and rising demand are increasingly converging.

Reflecting this shift, “Asia’s integrated resorts sector is entering a pivotal phase of transformation, as markets across the region continue to evolve with a broader mix of tourism, entertainment and lifestyle experiences,” said Yip Je Choong, Senior Vice President, Commercial, APAC, RX (Reed Exhibitions). “With G2E Asia and Asian IR Expo co-located, we are creating a platform that brings together stakeholders across the value chain to support innovation, collaboration and long-term, sustainable growth.”

Across the exhibition floor and conference programs, key industry leaders are actively engaging with peers to exchange insights and explore new opportunities for collaboration.

Leading Industry Figures Mark Opening Ceremony

The opening ceremony, held in the Expo Hall, officially marked the commencement of G2E Asia + Asian IR Expo 2026, with senior industry figures from across gaming, hospitality, and entertainment in attendance.

Guests included: (List to be provided)

Their participation reflects the industry’s sustained engagement and long-term commitment to advancing innovation across integrated resorts, gaming, and entertainment ecosystems.

Conference Programs Led by Global Industry Voices

G2E Asia and Asian IR Expo each feature dedicated three-day programs led by senior industry figures addressing technologies, regulations, and market forces shaping the sector’s future.

On Tuesday, May 12, Mr. Grant Chum, Chief Executive Officer and Executive Director of Sands China Ltd., delivers the opening keynote for G2E Asia Conference and Asian IR Summit, setting the strategic tone with insights into global industry trends shaping gaming and entertainment.

On Thursday, May 14, Mr. Mario Yau Kwan Ho, Chairman and Co-Chief Executive Officer of NIP Group INC., and Co-owner of Boston Celtics, is set to present a keynote for Asian IR Summit, offering perspectives on global market shifts and the evolving integrated resorts landscape.

Across both programs, speakers include:

• Mr. Adrian Lee, Head of Sales, Google Customer Solutions, Hong Kong & Macau, Google
• Mr. AI Watson, Chief Executive Officer, Dataworks Group
• Mr. Alan Teo, Chief Executive Officer, Hoiana Resort & Golf
• Mr. Cheng Wai Tong, Deputy Director, Macao Government Tourism Office
• Mr. Gregory Hawkins, President and Chief Operating Officer, Solaire
• Mr. Joseph Bufalino, Executive Director of Responsible Gambling, Marina Bay Sands
• Mr. Kenneth Feng, Chief Executive Officer and Executive Director, MGM China Holdings Limited
• Mr. Walt Power, Chief Executive Officer, The Grand Ho Tram
• And more.

Event Highlights Across May 12-14

Across three days, the co-located event presents a curated ecosystem of exhibition, education, and industry networking experiences.

Exhibition (May 12-14)
Discover innovation across gaming, entertainment, and integrated resorts, with more than 150 brands spanning the full industry ecosystem.

G2E Asia Conference (May 12-14)
Access critical market insights, regulatory developments, and business opportunities across Asia from the region’s leading platform for gaming and entertainment leaders.

Asian IR Summit (May 12-14)
Explore strategic insights across hospitality, technology, sports, and entertainment with senior leaders across the evolving integrated resorts sector.

Tech Talk (May 12)
Gain actionable insights from leading experts on leveraging Artificial Intelligence, applying Machine Learning in real-world operations, and using data to drive smarter, more profitable decisions.

May 12 Slots Networking:
Engage in exclusive roundtables for slots operators and suppliers to co-design next-generation gaming cabinets with embedded biometric feedback.

May 12 G2E Asia After Party:
Unwind with industry peers at a Venetian-themed gala featuring a live preview of 2027’s most anticipated VR casino suite.

May 13 Table Games Networking:
Exchange insights between operators and providers on gameplay evolution, innovation, and future table game ecosystems.

Be Part of the Future of Entertainment and Integrated Resorts

Industry professionals from gaming, entertainment, and integrated resorts sectors – including operators, providers, and hospitality experts – will gain strategic insights, networking opportunities, and explore cutting-edge innovations that are shaping the future of the sector.

Registration is available online and onsite.

To learn more about G2E Asia, visit www.G2EAsia.com.
To learn more about Asian IR Expo, visit www.AsianIRExpo.com.

Hashtag: #G2EAsia #AsianIRExpo2026

The issuer is solely responsible for the content of this announcement.

World-First Innovations Showcase Hong Kong’s Thriving Life and Health Tech Ecosystem from Bench to Bedside

HONG KONG SAR – Media OutReach Newswire – 12 May 2026 – Hong Kong Science and Technology Parks Corporation (HKSTP) joined alongside 38 Park companies in the two flagship events of the 5^th International Healthcare Week — the Hong Kong International Medical and Healthcare Fair (“Medical Fair”) and the Asia Summit on Global Health (“ASGH”), held from 11 – 13 May. Showcasing at these premier medical innovation and technology (I&T) events, HKSTP is demonstrating its pivotal role in nurturing and supporting the growth of biotechnology enterprises. During ASGH, HKSTP also hosted a dedicated investor pitch session, providing Park companies with an exclusive stage to connect directly with global capital and pursue fundraising opportunities.

Over 30 Market-Ready Solutions across Four Key Industry Focus

On the opening day of the Medical Fair, the HKSTP pavilion drew numerous industry professionals, investors and professional buyers, who gathered to explore Hong Kong’s latest I&T achievements and actively discuss collaboration opportunities. Participating companies span four critical areas — health monitoring, surgical assistance, precision medicine, rehabilitation training — comprehensively demonstrating the diverse strengths of Hong Kong’s life and health technology sector as it progresses from research and development (R&D) to commercial application.

Mr Terry Wong, CEO of HKSTP, said: “HKSTP has always been a steadfast partner to tech ventures, building a vibrant and well-established ecosystem for biotech companies ranging from start-ups with early-stage innovation to experienced innovators with market-ready solutions. To meet their diverse needs, we offer end-to-end support from R&D to clinical applications, including lab facilities, funding connections and market expansion. Our presence at this event fully reflects the innovative vitality and strength of Hong Kong’s life and health tech ecosystem. We hope to showcase Hong Kong’s cutting-edge medical R&D achievements to the international community, while delivering a clear message: Hong Kong is not only a top-tier scientific research base, but also the strongest springboard for technology enterprises to go global. By uniting forces across all sectors, we will further solidify Hong Kong’s leadership as an international health tech hub.”

Park company Highlights:

• Endovision offers an intestinal endoscopic imaging system that leverages AI and real-time imaging to assist physicians in conducting more precise examinations. The solution has already obtained EU Medical Device Regulation (MDR) certification.
• Mirror Caring presents SyncKnee, a smart wearable solution integrating flexible sensors, embedded systems and AI analytics to deliver real-time monitoring of knee joint health and data-driven insights.
• Voice Empowerment Technology features a customised “AI Voice Reconstruction Tool” designed to enhance the efficiency of speech therapy services, offering breakthrough communication support for patients with aphasia and speech disorders.

“World-First” Cutting-Edge Medical Technologies Take Centre Stage

This year, HKSTP has also set up a dedicated exhibition zone at the Asia Summit on Global Health (ASGH), spotlighting a range of groundbreaking biomedical solutions, including several “world-first” innovations:

• Agilis Robotics: The world’s first robotic-assisted “En Bloc Transurethral Resection of Bladder Tumour”, achieving precise tumour resection margins and offering a minimally invasive surgical option with faster recovery for early-stage cancer patients.
• GenEditBio: The world’s first in vivo genome editing therapy (often referred to as “DNA surgery”) targeting corneal dystrophy, with Phase I clinical trials expected to commence this year, aiming to improve patients’ quality of life.
• Meta Pharmaceuticals: The world’s first oral inhibitor for treating autoimmune diseases such as inflammatory bowel disease and multiple sclerosis, enhancing medication convenience and delivering safer, more effective anti-inflammatory therapy.

Dedicated Investor Pitch Session: Connecting Global Capital to Accelerate Enterprise Growth

For early-stage biotech companies, funding is crucial to sustaining research and achieving breakthroughs. To this end, HKSTP is fulfilling its role as a “super-connector” by hosting the “Life and Health Technology Innovation Pitch” at ASGH, to bridge between Park companies and the global market and deepen international partnerships.

The pitch session bought together 12 leading global investors from the UK, the US, Singapore, Canada and beyond, creating a top-tier platform for fundraising and business matching, and accelerating the translation of life and health tech innovations. Ten Park companies with breakthrough technologies took the stage to attract international capital, further showcase their innovative solutions and advance to the next stage of growth and global expansion.

Event Details:
Hong Kong International Medical and Healthcare Fair (Medical Fair)
Date: 11–13 May 2026
Venue: Hong Kong Convention and Exhibition Centre, Hall 3DE
HKSTP Booth: 3E-E06

Asia Summit on Global Health (ASGH)
Date: 11–12 May 2026
Venue: Hong Kong Convention and Exhibition Centre, Hall 3FG
HKSTP Booth: 3F-A11
Hashtag: #HKSTP

The issuer is solely responsible for the content of this announcement.

About Hong Kong Science and Technology Parks Corporation

Hong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001 to create a thriving I&T ecosystem grooming 13 unicorns, more than 17,000 research professionals and over 2,500 technology companies from 26 countries and regions focused on developing healthtech, AI and robotics, fintech and smart city technologies, etc.

Our growing innovation ecosystem offers comprehensive support to attract and nurture talent, accelerate and commercialise innovation for technology ventures, with the I&T journey built around our key locations of Hong Kong Science Park in Pak Shek Kok, InnoCentre in Kowloon Tong and three modern InnoParks in Tai Po, Tseung Kwan O and Yuen Long realising a vision of new industrialisation for Hong Kong, where sectors including advanced manufacturing, micro-electronics and biotechnology are being reimagined.

Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen plays positive roles in connecting the world and the mainland with our proximity, strengthening cross-border exchange to bring advantages in attracting global talent and allowing possibilities for the development of technology companies in seven key areas: Medtech, big data and AI, robotics, new materials, microelectronics, fintech and sustainability, with both dry and wet laboratories, co-working space, conference and exhibition facilities, and more.

Through our R&D infrastructure, startup support and enterprise services, commercialisation and investment expertise, partnership networks and talent traction, HKSTP continues to contribute in establishing I&T as a pillar of growth for Hong Kong.

More information about HKSTP is available at www.hkstp.org.

Short Courses Structured for Busy Professionals

For working adults who want targeted upskilling, SIM Academy’s course listing includes instructor-led programmes that are typically offered in short formats. The 1-day or 2-day course structure may appeal to professionals seeking to build capability while balancing work and personal commitments.

The topics covered reflect a mix of core workplace capabilities and emerging skill areas, including communication skills, cognitive skills, systems leadership, sustainability, as well as broader organisational and leadership competencies. Such short-format training has become a common feature within Singapore’s continuing education landscape, particularly among working adults seeking to remain competitive in a changing job market.

SkillsFuture Funded Training Courses

A number of SIM Academy’s professional development courses are eligible for SkillsFuture Credit and related funding schemes. These funding mechanisms are part of national efforts to encourage lifelong learning and support workforce transformation. The availability of funding-supported courses may lower barriers to participation for individuals and employers, particularly for those pursuing incremental skills upgrading.

Career Switch for mid‑career professionals

SIM Academy offers programmes under the SkillsFuture Career Transition Programme (SCTP). These programmes are designed for individuals considering a shift into new roles or sectors and typically run over 5-6 months. Programme structures may include a combination of classroom learning, practical projects and career support elements such as guidance on job search and career planning.

This reflects a broader trend in Singapore’s training ecosystem, where structured transition programmes are increasingly used to support workforce mobility and adaptation to new job roles.

Flexible Delivery Formats

SIM Academy’s programmes are delivered through a mix of in-person, online and blended learning formats. This allows participants to select learning modes that align with their schedules and professional commitments. Short courses are conducted throughout the year, primarily at SIM Management House, alongside digital learning options that support greater accessibility. Flexible delivery has become an increasingly important feature of professional education, particularly for working adults balancing training with full-time employment.

Part of a Broader Continuing Education Landscape

As industries continue to evolve, demand for continuous skills development remains a key focus within Singapore’s workforce strategy. Short courses, modular training and structured transition programmes are among the approaches adopted by training providers to meet these needs.

SIM Academy’s range of offerings includes shorter, skills-focused workshops and longer-duration programmes designed to support career transitions.

References

• SIM Academy: https://www.sim.edu.sg/professional-development/overview
• Courses offered by SIM Academy: https://www.sim.edu.sg/professional-development/courses/course-listing
• SkillsFuture Courses offered at SIM: https://www.sim.edu.sg/professional-development/courses/skillsfuture-courses
• SkillsFuture Career Transition Programme (SCTP): https://sctp.pd.sim.edu.sg

Hashtag: #SIMAcademy #SIMA

https://www.sim.edu.sg/

The issuer is solely responsible for the content of this announcement.

About SIM Academy

SIM Academy provides leading-edge professional development and enterprise solutions. SIM Academy offers over 300 executive and business programmes that help almost 10,000 professionals annually on average hone their competencies to drive business value and achieve peak personal and enterprise performance.

Our programmes encompass a comprehensive range of lifelong learning opportunities designed to empower professionals with the knowledge, skills, and competencies necessary to become effective change-makers and leaders in today’s volatile and uncertain business landscape.

For more information on SIM Academy, visit sim.edu.sg

Ms Lee said, “Africa holds a strategic position in the Global South, representing a vital engine of growth in an era of global economic uncertainty. Interconnectivity is the key to unlocking this potential, and Hong Kong plays a strategic role in linking capital, talent, and innovation and technology between Africa, the Chinese Mainland, and international markets to drive high-quality, multilateral growth. As the Government’s arm for both inward investment and Chinese Mainland enterprises aiming to go global, InvestHK facilitates two-way investment through strategic market insights, extensive global access, targeted promotion and policy facilitation. ”

Ms Lee will visit Johannesburg from May 10 to 13 to meet with representatives from the local chambers, financial institutions, banks, fintech interests, and business and professional services sectors. Extending her mission to Kigali, Rwanda, from May 13, Ms Lee will represent InvestHK at the Africa CEO Forum to drive high-level exchanges with C-suite executives from the continent’s leading multinationals.

African enterprises establishing a presence in Hong Kong can benefit from a globally recognised common law system and Asia’s most competitive tax regime. Most recently, Hong Kong has further sharpened its competitive edge by announcing a halve in the profits tax to 8.25 per cent from the standard 16.5 per cent for qualifying physical commodity traders. By combining this fiscal incentive with the city’s status as the world’s pre-eminent offshore Renminbi hub, Hong Kong offers African commodities exporters a high-liquidity, efficient gateway to Asian markets.

In line with the advancement of the National 15th Five-Year Plan, Hong Kong is leveraging its status as a “super connector” and “super value-adder” to support national development. As China-Africa economic relations pivot towards high-value trade and investment, Hong Kong is uniquely positioned to accelerate two-way capital flows – spurring growth across finance, shipping, and innovation and technology.

Citing the South African national rugby team’s recent first-ever title at the Hong Kong Sevens, Ms Lee emphasised that such vibrant people-to-people connections are not merely symbolic, but serve as a meaningful foundation for driving bilateral economic connection.
Hashtag: #InvestHK

The issuer is solely responsible for the content of this announcement.

Richard Cheng, Associate Commercial Director (Hong Kong & Macau) at BeOne, said: “We are honored to receive this award from the Hong Kong Commercial Times. BeOne has built differentiated capabilities across clinical development and manufacturing, supported by a broad and diverse R&D pipeline. In Hong Kong, we have introduced several therapies, including BTK, PD-1 and IL-6 inhibitors. Looking ahead, we will continue to advance our plans in Hong Kong by leveraging opportunities enabled by the ‘1+’ policy and the planned establishment of the Hong Kong Centre for Medical Products Regulation (CMPR) and its ‘primary evaluation’ mechanism. Supported by our global supply network, we aim to bring additional medicines to patients in Hong Kong and the Greater Bay Area and help improve access to treatments aligned with international standards.”

Global R&D and Innovation

Founded in 2010, BeOne is focused on accelerating key stages of oncology innovation—from discovery through development to patient access. Through an integrated model spanning R&D, manufacturing and commercialization, the company works to translate innovation into clinical value. Today, BeOne operates across six continents in more than 45 markets and is supported by more than 1,200 oncology R&D professionals.

BeOne’s R&D platform has advanced more than 35 clinical-stage drug candidates, including three internally developed products that have received commercial approval, reaching more than 2 million patients worldwide.

Pipeline Highlights

BeOne continues to expand its global footprint through a portfolio of internally developed products, including:

• BTK Inhibitor: As the company’s first self-developed innovative drug, it holds a significant position in the global market (including Hong Kong), particularly in the field of B-cell malignancies.
• PD-1 Inhibitor: Launched in more than 50 markets worldwide, reaching 1.8 million people. In Hong Kong, it has been approved for six indications, including immunotherapy for lung, esophageal and gastric cancers.
• Next-Generation BCL-2 Inhibitor: Approved for certain lymphoma indications in Mainland China. It has been granted Priority Review by the U.S. Food and Drug Administration, and a marketing application has been submitted in the European Union.

Manufacturing Network Supporting Global Supply

BeOne maintains an integrated chain from R&D to manufacturing and commercialization, supported by production sites in the United States and China designed to help maintain a stable global supply:

• New Jersey, U.S.: A North America biologics hub integrating manufacturing and clinical R&D. The site spans 1.82 million square feet, including a dedicated 400,000-square-foot production facility.
• Suzhou, China (small molecule manufacturing): Supports clinical and commercial-scale production in accordance with applicable FDA, EMA and GMP requirements.
• Guangzhou, China (biologics and ADC manufacturing): A 1.3 million-square-foot facility supporting R&D and production of antibody-drug conjugates (ADCs) and serving as a supply hub for the Greater Bay Area, including Hong Kong.

BeOne has also been recognized by industry organizations for its innovation, including being named one of the “Top 10 Most Inventive” pharmaceutical companies by IDEA Pharma in 2025^[1]. The company will continue to advance programs in hematologic malignancies and solid tumors, with Hong Kong serving as a strategic hub to support the delivery of innovative therapies globally.

1. 2025 Pharmaceutical Innovation and Invention Index, IDEA Pharma

This material is intended for the purpose of communicating disease-related knowledge and cutting-edge medical information to the public and is not intended for promotional or advertising purposes. It does not constitute a promotion or recommendation for any medication or treatment plan, nor can it serve as a substitute for the advice of medical and health professionals. If you have any questions, please consult a medical or health professional.

Hashtag: #BeOneMedicines

https://www.beonemedicines.com/

The issuer is solely responsible for the content of this announcement.

About BeOne Medicines

BeOne Medicines is a global oncology company domiciled in Switzerland, focused on discovering and developing innovative treatments designed to be more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is advancing a diverse pipeline of novel therapeutics through internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to improving access to medicines for more patients. To learn more about BeOne, please visit www.beonemedicines.com and follow us on LinkedIn, X, Facebook and Instagram.

About HKCT Business Awards 2026

Organized by the Hong Kong Commercial Times, the HKCT Business Awards is a representative annual event in the Hong Kong business community. It honors companies demonstrating excellence, innovation, and significant contributions to Hong Kong’s economy and society across dimensions including technological innovation and market competitiveness.